Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral control: the PIILR extension study.

AIDS

National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia.

Published: December 2002

Download full-text PDF	Source
http://dx.doi.org/10.1097/00002030-200212060-00020	DOI Listing

Publication Analysis

thymidine analogue

analogue withdrawal

withdrawal lipoatrophic

lipoatrophic patients

patients protease-sparing

protease-sparing therapy

therapy improves

improves lipoatrophy

lipoatrophy compromises

compromises antiviral

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!